Albert Labs Overview
- Year Founded
-
2020
- Status
-
Public
- Stock Symbol
-
ABRT
Albert Labs General Information
Description
Albert Labs International Corp is a laboratory-based, clinical research, and drug development enterprise addressing mental health care needs. The company is focusing on Real World Evidence (RWE) the company will initially look to commercialize its mycelium-based KRN-101 medicine and treatment with the help of a clinical pathway.
Contact Information
Website
www.albertlabs.comCorporate Office
- 6996, Merritt Avenue
- Burnaby, British Columbia V5J 4R6
- Canada
Corporate Office
- 6996, Merritt Avenue
- Burnaby, British Columbia V5J 4R6
- Canada
Albert Labs Timeline
Albert Labs Stock Performance
As of 15-Jul-2024, Albert Labs’s current market cap is $273K with 74.4M shares.
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $273K | 74.4M | 71.8K | -$0.04 |
Albert Labs Financials Summary
As of 30-Sep-2023, Albert Labs has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Sep-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|
| EV | 1,103 | ||
| Revenue | 0 | 0 | 0 |
| EBITDA | (1,697) | (5,415) | (1,496) |
| Net Income | (1,709) | (5,418) | (1,498) |
| Total Assets | 48 | 121 | 281 |
| Total Debt | 7 |
Albert Labs Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Albert Labs Comparisons
Industry
Financing
Details
Albert Labs Competitors (2)
One of Albert Labs’s 2 competitors is Definium Therapeutics, a Formerly VC-backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Definium Therapeutics | Formerly VC-backed | New York, NY | ||||
| COMPASS Pathways | Formerly VC-backed | Altrincham, United Kingdom |
Albert Labs Patents
Albert Labs Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023023857-A1 | Method and system for culturing filamentous organisms | Inactive | 24-Aug-2021 |
Albert Labs Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Albert Labs ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Albert Labs FAQs
-
When was Albert Labs founded?
Albert Labs was founded in 2020.
-
Where is Albert Labs headquartered?
Albert Labs is headquartered in Burnaby, Canada.
-
What industry is Albert Labs in?
Albert Labs’s primary industry is Drug Discovery.
-
Is Albert Labs a private or public company?
Albert Labs is a Public company.
-
What is Albert Labs’s stock symbol?
The ticker symbol for Albert Labs is ABRT.
-
What is the current market cap of Albert Labs?
The current market capitalization of Albert Labs is $273K.
-
Who are Albert Labs’s competitors?
Definium Therapeutics and COMPASS Pathways are competitors of Albert Labs.
-
What is Albert Labs’s annual earnings per share (EPS)?
Albert Labs’s EPS for 12 months was -$0.04.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process